The fact that FOXP3+ TILs, in contrast to CD8+ and CD4+ TILs, did not decrease in inner tumor areas further suggests that regulatory T-cells may better survive in the microenvironment of the tumor body. This evidence concerns the gene FOXP3 and neoplasm.